Codexis, a leader in enzymatic solutions for therapeutics manufacturing, has secured a $60 million senior secured term loan from Trinity Capital. The initial $42.5 million drawdown was used to refinance existing debt, improving Codexis's financial flexibility. The loan features 48 months of interest-only payments followed by a 12-month amortization period starting in November 2030. This financing supports Codexis's growth initiatives, particularly the industrialization of its ECO Synthesis platform for siRNA therapeutics, aiming to enhance manufacturing efficiency and scale.
Codexis's recent $60 million term loan facility provides context for health sector activity on Pluang. As of Nov 10, 2026 17:11 WIB, 70 of 150 priced health-sector US stocks rose while 65 fell. Notable movers include CGC at USD 0.65 with a 4.37% gain and HIMS at USD 22.04 with a 3.92% loss in one day.
Iveco Group is exhibiting its latest products, including new light and heavy-duty vehicles powered by FPT engines, at Fenatran 2026 in São Paulo, highlighting its strong industrial and commercial presence in Latin America. The event marks the regiona...
The global paracetamol market is projected to grow from $12.05 billion in 2026 to $15.39 billion by 2032, with a CAGR of 4.12%. Growth is driven by increasing demand for pain and fever management, expanded access to over-the-counter medicines, and in...
ESET Research uncovered a sophisticated cyberespionage tool named Cereal, used by the Russia-aligned Turla group to spy on emails within Microsoft Exchange servers of governmental organizations in Kazakhstan and Romania. The tool stealthily collects ...
Registration is now open for Brand Licensing Expo 2027, scheduled for May 25-27 at Mandalay Bay, Las Vegas. The event, rebranded from Licensing Expo, features over 265 confirmed exhibitors including major brands like Amazon MGM Studios, Coca-Cola, an...
Wix reported Q3 2026 earnings per share of $1.42, surpassing the $1.40 estimate, and revenue of $570.2 million, exceeding the $566.3 million forecast. Bookings grew 11% to $573 million, with revenue up 13%, driven mainly by Base44's strong performanc...
